SINOPHARM TECH: COMPANY INFORMATION SHEET
SINOPHARM TECH: NEXT DAY DISCLOSURE RETURN
SINOPHARM TECH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
SINOPHARM TECH: EFFECTIVE DATE OF THE CAPITAL REORGANISATION AND FREE EXCHANGE OF SHARE CERTIFICATES
SINOPHARM TECH: FURTHER UPDATE ON THE CAPITAL REORGANISATION AND REVISED EXPECTED TIMETABLE
SINOPHARM TECH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
SINOPHARM TECH: UPDATE ON THE CAPITAL REORGANISATION AND REVISED EXPECTED TIMETABLE
SINOPHARM TECH: INSIDE INFORMATION (1) DELAY IN PUBLICATION OF 2024 ANNUAL RESULTS AND DESPATCH OF ANNUAL REPORT 2024; AND (2) SUSPENSION OF TRADING
SINOPHARM TECH: EXCHANGE NOTICE - SUSPENSION OF TRADING
SINOPHARM TECH: CHANGE OF AUDITORS
SINOPHARM TECH: INSIDE INFORMATION POSSIBLE DELAY IN PUBLICATION OF THE 2024 ANNUAL RESULTS; POSSIBLE POSTPONEMENT OF THE BOARD MEETING; AND POSSIBLE SUSPENSION OF TRADING
SINOPHARM TECH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
SINOPHARM TECH: CHANGE OF AUDITORS
SINOPHARM TECH: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 8 AUGUST 2024; AND GRANT OF WHITEWASH WAIVER
SINOPHARM TECH: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024
SINOPHARM TECH: DESPATCH OF CIRCULAR IN RELATION TO (1)PROPOSED CAPITAL REORGANISATION; (2)CONNECTED TRANSACTIONS: LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE; (3)APPLICATION FOR WHITEWASH WAIVE
SINOPHARM TECH: FORM OF PROXY
SINOPHARM TECH: (1)PROPOSED CAPITAL REORGANISATION;(2)CONNECTED TRANSACTIONS:LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE;(3)APPLICATION FOR WHITEWASH WAIVER;(4)LOAN CAPITALISATION INVOLVING ISSU
SINOPHARM TECH: NOTICE OF EXTRAORDINARY GENERAL MEETING
SINOPHARM TECH: CLOSURE OF REGISTER OF MEMBERS FOR EXTRAORDINARY GENERAL MEETING
No Data
No Data